Basu, Sandip <br/><br/>
Should grade of tracer uptake on somatostatin receptor-targeted imaging be the major determinant and break the barrier of histopathologic criteria for determining the suitability of Peptide receptor radionuclide therapy?  [electronic resource] 

 -  Journal of nuclear medicine : official publication, Society of Nuclear Medicine  Nov 2013 
 - 2018-9 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1535-5667 
<br/><br/><label>Standard No.: </label>10.2967/jnumed.113.127829  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>International Agencies<br/>Molecular Targeted Therapy--methods<br/>Neuroendocrine Tumors--radiotherapy<br/>Nuclear Energy<br/>Radiotherapy--methods<br/>Receptors, Peptide--metabolism<br/>Societies, Scientific